Antiviral Drug Development and Treatment Strategies

Antiviral drugs are a class of medication used specifically for treating viral infections. Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic (also termed antibacterial), antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Outbreaks of influenza happen each year and regularly achieve pandemic levels at some part of the season. Antiviral medications are a second line of protection framework against flu contamination. The antiviral medications have been affirmed for treatment of intense uncomplicated flu and for some preventive employments. Tamiflu (oseltamivir phosphate), Relenza (zanamivir) and Rapivab (peramivir) are the three FDA-affirmed flu antiviral medications suggested by CDC for use against as of late coursing flu infections. There is a great need for antiviral drugs with increased potency and decreased toxicity. The Center for Disease Control and Prevention has estimated that routine immunization of newborns prevents about 42,000 deaths and 20 million cases of disease each year, saving about $13.6 billion.

  • Approaches to antiviral drug development
  • Adjuvant and immune-modulatory therapies
  • Anti-viral targeting
  • Effectiveness of antivirals

Are you interested in

Mail us at

For Program Enquiry
influenza@alliedconferences.org
Sponsors/Exhibitors
influenza@alliedmeetings.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.